Sector: Cannabis
Geography: United States
COMM_GTBIF
Net debt (table and EV/EBITDA): |short-term borrowings| + |long-term borrowings| + |other financial liabilities| when extracted + |non-controlling interest| when extracted − |cash and equivalents|; amounts in millions of the reporting currency.
Shares: yahoo_fundamentals_timeseries/GTBIF
| Period | Issues |
|---|---|
| 2023-03-31 Q1 | ⚠Warn 1 |
| 2023-06-30 Q2 | ⚠Warn 1 |
| 2023-09-30 Q3 | ⚠Warn 1 |
| 2023-12-31 FY | ⚠Warn 1 |
| 2023-12-31 Q4 | ⚠Warn 1 |
| 2024-03-31 Q1 | ⚠Warn 1 |
| 2024-06-30 Q2 | ✗Errors 1Warn 1 |
| 2024-09-30 Q3 | ⚠Warn 1 |
| 2024-12-31 FY | ⚠Warn 1 |
| 2025-03-31 Q1 | ⚠Warn 1 |
| 2025-06-30 Q2 | ⚠Warn 3 |
| 2025-09-30 Q3 | ⚠Warn 1 |
| 2025-12-31 FY | ⚠Warn 1 |
| 2026-03-31 Q1 | ✗Errors 1Warn 1 |
Monetary columns are in M USD, one decimal; scale (K/M/B/T) keeps values readable. For the period (default) shows P&L and cash flow for that row’s reporting window: quarterly amounts when the feed uses quarter-duration facts (typical US 10-Q revenue and income), quarterly cash flows after stripping YTD where only cumulative tags exist, and an implied Q4 on 31 Dec FY rows (P&L: FY minus Q1–Q3; operating / investing cash flow: FY 12m minus 9M YTD to 30 Sep when sourced from SEC builder evidence) so they match 10-Q scale. Some issuers still use cumulative YTD minus the prior row in the same calendar year. As reported shows values stored on each row (e.g. full-year on FY). Balance sheet is always as reported. Source JSON may use millions etc.; conversion uses amounts_unit per row.
| Date | Period | Status | RevenueM USD | Operating profitM USD | D&AM USD | EBITDAM USD | Net profitM USD | Operating CFM USD | Capex + M&AM USD | AssetsM USD | EquityM USD | ROE (annualized) | Net debtM USD | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | Q1 2026 (3M) | OK | 300.2 y/y 7.4% | 40.7 y/y -4.1% | 32.4 y/y 10.2% | 73.1 y/y 1.7% | 15.4 y/y 85.4% | 75.8 | -18.9 | 2831.6 y/y 10.2% | 1893.0 y/y 4.8% | 3.2% | -35.6 | Link |
| 2025-12-31 | Q4 2025 (3M) | OK | 311.1 y/y 5.7% | 19.0 y/y -66.7% | 56.3 y/y 94.4% | 75.3 y/y -12.5% | 83.2 y/y 556.2% | 90.1 | -14.7 | 2790.1 y/y 10.0% | 1905.4 y/y 6.5% | 6.1% | 9.8 | Link |
| 2025-09-30 | Q3 2025 (3M) | OK | 291.4 y/y 1.6% | 36.7 y/y -13.8% | 30.1 y/y 5.6% | 66.8 y/y -6.0% | 23.3 y/y 170.3% | 74.1 | -17.5 | 2639.2 y/y 4.9% | 1828.4 y/y 3.0% | 1.7% | 37.9 | Link |
| 2025-06-30 | Q2 2025 (3M) | OK | 293.3 y/y 4.7% | 39.4 y/y -27.0% | 29.7 y/y 6.0% | 69.1 y/y -15.7% | -0.6 y/y -103.1% | 56.4 | -19.0 | 2548.2 y/y 0.3% | 1793.2 y/y 2.2% | -0.1% | 89.0 | Link |
| 2025-03-31 | Q1 2025 (3M) | OK | 279.5 y/y 1.4% | 42.5 y/y -39.9% | 29.4 y/y 5.9% | 71.9 y/y -27.0% | 8.3 y/y -73.3% | 74.2 | -29.8 | 2569.1 y/y 0.6% | 1807.2 y/y 3.4% | 1.8% | 56.7 | Link |
| 2024-12-31 | Q4 2024 (3M) | OK | 294.3 y/y 5.8% | 57.1 y/y 13.4% | 29.0 y/y 5.6% | 86.1 y/y 10.7% | 12.7 y/y 294.2% | 43.3 | -27.2 | 2537.0 y/y 1.9% | 1789.3 y/y 5.1% | 4.1% | 112.7 | Link |
| 2024-09-30 | Q3 2024 (3M) | OK | 286.9 y/y 4.2% | 42.6 y/y -13.1% | 28.5 y/y 11.2% | 71.1 y/y -4.7% | 8.6 y/y -18.0% | 47.7 | -18.0 | 2514.9 y/y 0.6% | 1774.8 y/y 4.0% | 0.7% | 95.3 | Link |
| 2024-06-30 | Q2 2024 (3M) | OK | 280.1 y/y 11.0% | 54.0 y/y 31.6% | 28.0 y/y 15.5% | 82.0 y/y 25.6% | 20.7 y/y 54.6% | 20.2 | -20.3 | 2540.6 y/y 1.1% | 1753.9 y/y 2.8% | 4.7% | -183.3 | Link |
| 2024-03-31 | Q1 2024 (3M) | OK | 275.8 y/y 11.0% | 70.7 y/y 59.9% | 27.8 y/y 18.2% | 98.4 y/y 45.4% | 31.1 y/y 240.0% | 84.0 | -14.7 | 2554.8 y/y 2.5% | 1747.0 y/y 3.9% | 7.2% | 98.8 | Link |
| 2023-12-31 | Q4 2023 (3M) | OK | 278.2 y/y — | 50.3 y/y — | 27.4 y/y — | 77.8 y/y — | 3.2 y/y — | 71.1 | -36.4 | 2490.1 y/y — | 1702.9 y/y — | 2.1% | 159.2 | Link |
| 2023-09-30 | Q3 2023 (3M) | OK | 275.4 y/y — | 49.0 y/y — | 25.6 y/y — | 74.7 y/y — | 10.5 y/y — | 60.8 | -54.2 | 2499.2 y/y — | 1706.3 y/y — | 0.8% | 173.5 | Link |
| 2023-06-30 | Q2 2023 (3M) | OK | 252.4 y/y — | 41.1 y/y — | 24.2 y/y — | 65.3 y/y — | 13.4 y/y — | 18.3 | -64.4 | 2512.8 y/y — | 1705.3 y/y — | 3.2% | 153.1 | Link |
| 2023-03-31 | Q1 2023 (3M) | OK | 248.5 y/y — | 44.2 y/y — | 23.5 y/y — | 67.7 y/y — | 9.1 y/y — | 74.7 | -65.0 | 2493.2 y/y — | 1680.8 y/y — | — | 104.2 | Link |
Quarterly values ($ mln)
Year-over-year change
FCF ($ mln)
Net debt / cash ($ mln)
Current 1 003spot vs LTM -5%
Target market cap from conservative EBITDA and the historical EV/EBITDA
Upside: -34.1%
Main driver: Cannabis Spot Index -5% vs LTM; revenue ×0.95 vs costs ×1.04; EBITDA 284→185; at 5.8× EV/EBITDA → -34%.
Product prices — moves vs the LTM average
| Commodity | Share | Spot | LTM | 3-yr | vs LTM, $ | 3y vs LTM |
|---|---|---|---|---|---|---|
| Cannabis Spot Index (rev) | +100% | 1 003.00 | 1 060.68 | 1 055.17 | -5% | -1% |
| Electricity Spot (cost) | -5% | 57.80 | 58.56 | 52.39 | -1% | -11% |
How it is calculated — revenue → costs → EBITDA → target market cap
| 1 · Reported baseline (LTM) | |
| LTM revenue | 1 196 |
| LTM EBITDA | 284 |
| LTM cash costs (revenue − EBITDA) | 912 |
| 2 · Revenue projection | |
| Revenue multiplier — spot | ×0.946 (-5%) |
| = Spot revenue | 1 131 |
| Revenue multiplier — 3y price | ×0.995 (-1%) |
| = 3-year-price revenue | 1 190 |
| 3 · Costs projection | |
| Cost multiplier — spot | ×1.037 (+4%) |
| = Spot cash costs | 946 |
| Cost multiplier — 3y price | ×1.033 (+3%) |
| = 3-year-price cash costs | 941 |
| 4 · EBITDA projection (revenue − costs) | |
| = Spot EBITDA | 185 |
| = 3-year-price EBITDA | 248 |
| Conservative EBITDA = min(spot, avg) | 185 |
| 5 · Valuation → target market cap | |
| Historical EV/projected-EBITDA (75th pct) | 5.8x |
| Target EV = EV/EBITDA × conservative EBITDA | 1 067 |
| Net debt | -36 |
| Target market cap = EV − net debt | 1 103 |
| Current market cap | 1 674 |
Upside = target market cap ÷ current − 1 = -34.1%
Spot model vs reported — what the spot model projected (trailing-LTM base brought to the period × the period's commodity-price move) against the actual report, per reported period (quarter, half-year or full year — per the filer's calendar); amounts in USD mln. green = reported above projection, pink = below.
| Period | Act. rev | Model rev | Δ rev | Act. EBITDA | Model EBITDA | Δ EBITDA |
|---|---|---|---|---|---|---|
| 2023 Q2 | 252 | 260 | -2.8% | 65 | 57 | +15.2% |
| 2023 Q3 | 275 | 250 | +10.1% | 75 | 41 | +81.7% |
| 2023 Q4 | 278 | 277 | +0.5% | 78 | 61 | +27.0% |
| 2024 Q1 | 276 | 267 | +3.4% | 98 | 71 | +38.5% |
| 2024 Q2 | 280 | 268 | +4.6% | 82 | 71 | +15.7% |
| 2024 Q3 | 287 | 268 | +7.1% | 71 | 69 | +3.3% |
| 2024 Q4 | 294 | 264 | +11.6% | 86 | 60 | +43.6% |
| 2025 Q1 | 280 | 269 | +3.8% | 72 | 63 | +13.5% |
| 2025 Q2 | 293 | 289 | +1.4% | 69 | 75 | -8.4% |
| 2025 Q3 | 291 | 324 | -10.1% | 67 | 104 | -35.7% |
| 2025 Q4 | 311 | 322 | -3.5% | 75 | 99 | -23.6% |
| 2026 Q1 | 300 | 294 | +1.9% | 73 | 65 | +12.0% |
Projected EV/EBITDA 5.9x · target 75th pct (3y) 5.8x · LTM avg 8.9x
No dividend rows found for this issuer (checked: Yahoo Finance (ex-div)).
Reporting forms detected in loaded periods: ✓ ✓ ✓ (Balance sheet / Profit or loss (P&L) / Cash flows)